I am unable to provide an introduction for the stock with the ticker "ESLT" as insufficient company information was provided.
Please review the available company details, including its name, sector, and description, to ensure an accurate analysis can be prepared.
Updated: February 19, 2026, 16:00 EST
Technical Analysis: ESLT shows strong momentum despite consolidation near its all-time high. Its negative beta indicates unusual independence from market trends, though entering at current levels offers limited discount from recent peaks. The stock appears to be pausing after a significant rally, suggesting patience may be prudent.
Fundamentals: The company maintains solid profitability and conservative leverage, though operational efficiency shows some strain with extended cash conversion cycles. Revenue moderation in the latest quarter is balanced by improving net margins and adequate cash flow coverage of obligations.
Valuation: Current multiples appear stretched, with exceptionally high PE and EV/EBITDA ratios suggesting substantial growth expectations are already priced in. The elevated PEG ratio indicates valuation may not be supported by near-term earnings growth potential.
Risk: The negative beta introduces unconventional portfolio dynamics, while minimal short interest reduces squeeze risk but may reflect lower market engagement. Working capital inefficiencies represent an operational watch point.
Investment Recommendation:
ESLT demonstrates strong operational foundations but trades at premium valuations that appear demanding. While the company's counter-cyclical characteristics and profitability are attractive, current prices likely incorporate much of the positive outlook. Investors might consider waiting for a more attractive entry point or a clear catalyst that justifies the elevated multiples. The stock appears better suited for watchlists than immediate purchase at current levels.
Based on the provided analysis, here is a 12-month outlook for ESLT:
The primary catalyst for ESLT over the next year is its strong operational foundation and unique counter-cyclical characteristic, as indicated by its negative beta, which could provide defensive stability if broader market conditions weaken. However, significant risks are present, primarily stemming from its exceptionally stretched valuation and already high growth expectations, which leave little room for disappointment and make the stock vulnerable to a downturn if operational efficiencies do not materially improve. With no clear analyst target price available and the stock consolidating near all-time highs, a prudent 12-month target range is difficult to establish; investors should await a more attractive entry point or a fundamental catalyst that justifies the current premium multiples before considering a position.
Most Wall Street analysts are optimistic about Elbit Systems Ltd.'s 12-month outlook, with consensus target around $730.31, indicating expected upside potential.
Overall, ESLT has investment potential but also faces challenges. Here are key factors to weigh before investing.
ESLT demonstrates exceptional long-term momentum despite recent volatility, with the stock delivering dramatic outperformance versus the market over the past quarter. Over the short term, the stock has retreated slightly in the past month after a massive 45.32% surge over three months, significantly outperforming the broader market by over 45 percentage points during that period.
Currently trading at $702.07, ESLT is positioned near the upper end of its 52-week range, approximately 5.2% below its all-time high of $740.67. The stock appears to be consolidating after its recent parabolic advance, with its negative beta suggesting it behaves counter to broader market trends. Given its proximity to the 52-week high, the stock is not in an oversold condition.
| Period | ESLT Return | S&P 500 |
|---|---|---|
| 1m | +2.7% | +1.0% |
| 3m | +54.9% | +1.9% |
| 6m | +67.0% | +6.5% |
| 1y | +143.2% | +12.1% |
| ytd | +23.4% | +0.2% |
Revenue & Profitability ESLT's Q3 2025 revenue of $1.95 billion shows a sequential moderation from Q2's $2.09 billion. The company maintains solid profitability with a gross profit margin of 24.9% and an improving net income margin of 6.94% versus 6.37% in the prior quarter, indicating better cost control despite the revenue dip.
Financial Health The company demonstrates conservative leverage with a low debt-to-equity ratio of 0.27 and a strong interest coverage of nearly 5x. However, the cash ratio is minimal at 0.025, suggesting limited liquid assets, though operating cash flow per share of $3.39 provides adequate coverage for ongoing obligations.
Operational Efficiency ESLT's operational efficiency shows mixed signals with a respectable return on equity of 3.38% but relatively low asset turnover of 0.16. The extended cash conversion cycle of 242 days, driven by high days sales outstanding (145) and inventory days (193), indicates potential working capital management challenges affecting capital efficiency.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardValuation Level ESLT appears substantially overvalued based on its current valuation metrics. The TTM PE ratio of 71.23 and forward PE of 43.33 are exceptionally high, indicating investors are paying a significant premium for its earnings. This is further underscored by the elevated EV/EBITDA of 111.06 and a PEG ratio of 7.47, which suggests the high valuation is not justified by its expected earnings growth rate.
Peer Comparison A peer comparison cannot be conclusively performed as industry average data is unavailable. However, the extremely high PE, EV/EBITDA, and PEG ratios are typically indicative of a valuation that is significantly above average for most mature industries. Without specific benchmarks, the analysis relies on the premise that such multiples are unsustainable outside of exceptionally high-growth sectors.
Volatility Risk ESLT exhibits unusual volatility characteristics with a negative beta of -0.217, implying the stock historically moves inversely to the broader market. This can introduce unique portfolio risks, as the stock may not provide expected diversification during market downturns. The 1-year maximum drawdown of -13.56% is relatively moderate for an equity, suggesting contained historical downside volatility.
Other Risks A notable feature is the apparent absence of short interest, which reduces the risk of a short squeeze but may also indicate low market scrutiny or speculative activity. While eliminating one source of price pressure, this could point to potential liquidity concerns or subdued investor interest, which may impact trading efficiency.
Based on the provided analysis, I am bearish on ESLT at its current price. The stock appears substantially overvalued with an extremely high P/E of 71, and this is further supported by a unanimous "Sell" rating from analysts. Furthermore, the recent parabolic price surge increases the risk of a pullback. This stock is not suitable for most investors at this level, particularly value-focused or risk-averse investors.
Based on the provided data, ESLT appears substantially overvalued. Its valuation metrics are exceptionally high, with a TTM PE of 71.2, a forward PE of 43.3, and a PEG ratio of 7.47, which are unsustainable outside of hyper-growth sectors. These multiples suggest the market has priced in extremely optimistic future growth that is not supported by the company's current moderate profitability (6.94% net margin) and operational efficiency challenges, such as a 242-day cash conversion cycle. While the company is financially healthy, its valuation is disproportionately high relative to its fundamental performance.
Based on the provided information, here are the key risks of holding ESLT stock, ordered by importance:
1. Market Correlation Risk: The stock's significant negative beta (-0.217) creates a non-diversification risk, as its tendency to move opposite the broader market could lead to underperformance during sustained market rallies. 2. Liquidity and Working Capital Risk: An extremely low cash ratio (0.025) combined with a very long cash conversion cycle (242 days) indicates potential vulnerability to meeting short-term obligations and inefficiency in managing working capital. 3. Valuation and Momentum Risk: Trading near its 52-week high after a recent parabolic price surge (over 45% in three months) increases the risk of a sharp pullback as the stock consolidates its dramatic gains.
Based on the provided analysis, a 2026 forecast for ESLT is inherently speculative due to the stock's stretched valuation and high expectations that leave little room for error. A base case scenario would likely involve modest growth, resulting in a target price range of $700 to $750, assuming the company can improve its capital efficiency (notably the 242-day cash conversion cycle) while maintaining its counter-cyclical defensive characteristics. A bull case, dependent on significant operational improvements and a successful execution of growth initiatives, could push the stock toward $800, but this is highly contingent on strong execution and favorable market conditions. The primary uncertainty lies in whether the company's future profitability can justify its current premium valuation, making this forecast highly sensitive to any operational disappointments.